Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE LIABILITY (Details Narrative)

v3.23.1
DERIVATIVE LIABILITY (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Jul. 28, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Fair value of derivative liabilities $ 36,868   $ 36,868  
Gain (Loss) on Sale of Derivatives 0      
Loan and Security Agreement [Member] | K2 HealthVentures LLC [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Secured debt $ 21,590,000     $ 50,000,000
Gain (Loss) on Sale of Derivatives   $ 0    
Loan and Security Agreement [Member] | K2 HealthVentures LLC [Member] | Share-based Payment Arrangement, Tranche One [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Secured debt       $ 20,000,000